Articles by Texas Biomedical Research Institute

Research will assess the efficacy of surface coating and aerosolized decontamination technologies to combat SARS-CoV-2 and other respiratory pathogens on surfaces and in the air

Animal models are a critical component of the biomedical pipeline necessary to fast-track drug and vaccine development

Acute infections in male marmosets, a New World monkey, resemble the human illness the Zika virus creates in people

Malaria researchers use new genomic tools to individualize parasite analysis. 

In the most extensive screen of its kind, Texas Biomed scientists have demonstrated the feasibility of repurposing already-approved drugs for use against highly pathogenic bacteria and viruses. The pathogens included emerging diseases and potential bioterror threats ranging from anthrax to the Marburg and Ebola viruses.